Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Carbylan Therapeutics, Inc.

Home Clinical Trial Sponsors and OrganizationsCarbylan Therapeutics, Inc.

Carbylan Therapeutics, Inc.

CLOSED

加利福尼亚州圣克拉拉县, California, United Stateswww.carbylan.comPrivate11–50 employeesEstablished: 2005-01-01

Part of KalVista Pharmaceuticals

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

5

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2005

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

1

20.0%

Phase 2

1

20.0%

Phase 3

1

20.0%

Phase 4

1

20.0%

Trial Status Distribution

Completed

4

80.0%

Terminated

1

20.0%

Clinical Trials

Trials sponsored by this organization (5)

Hydros and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis

Jan 2014510 participants

Hydros Joint Therapy and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis (OA)

Apr 201098 participants

ActaVisc and ActaVisc Mx Intra-articular Injection for Pain Associated With Osteoarthritis in the Knee

Mar 200823 participants

Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel

May 200729 participants

Hydros and Hydros-TA Joint Therapy for Pain Associated with Knee OA; A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated with Osteoarthritis in the Knee

210 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials5
Approvals
News

Back to Organizations